Detalhe da pesquisa
1.
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
Lancet Oncol
; 25(2): 175-183, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218192
2.
Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study.
BMC Cancer
; 24(1): 146, 2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287346
3.
225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings.
Eur J Nucl Med Mol Imaging
; 50(7): 2210-2218, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864360
4.
Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?
Int J Mol Sci
; 24(21)2023 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958683
5.
Comparative Analysis of Morphological and Functional Effects of 225Ac- and 177Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands.
Int J Mol Sci
; 24(23)2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38069166
6.
Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 49(10): 3581-3592, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384462
7.
Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter 213Bi.
Mol Pharm
; 19(8): 2818-2831, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849547
8.
Global experience with PSMA-based alpha therapy in prostate cancer.
Eur J Nucl Med Mol Imaging
; 49(1): 30-46, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173838
9.
Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma - safety and efficacy.
Eur J Nucl Med Mol Imaging
; 48(11): 3595-3605, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860346
10.
Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity.
Eur J Nucl Med Mol Imaging
; 49(1): 54-63, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448031
11.
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.
Mol Pharm
; 17(9): 3553-3566, 2020 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32787284
12.
Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer.
Curr Opin Urol
; 30(1): 98-105, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31644433
13.
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer.
Molecules
; 25(5)2020 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106568
14.
Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma.
Eur J Nucl Med Mol Imaging
; 46(3): 614-622, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30498897
15.
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.
Eur J Nucl Med Mol Imaging
; 46(1): 129-138, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232539
16.
Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT.
Eur J Nucl Med Mol Imaging
; 46(1): 139-147, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30151743
17.
Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.
Eur J Nucl Med Mol Imaging
; 46(10): 1988, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31240331
18.
DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay.
Mutagenesis
; 34(3): 239-244, 2019 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31107537
19.
Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.
J Labelled Comp Radiopharm
; 62(11): 794-802, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31369165
20.
Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617.
Eur J Nucl Med Mol Imaging
; 45(1): 31-37, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28891033